Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

Clinical Validation of InferRead Lung CT.AI

See Locations Near You

Summary

Lung cancer is the second most common cause of cancer-related death in men and women. Early pulmonary nodule screening is an effective means to prevent lung cancer, which is no less important than the diagnosis and treatment of lung cancer. Early lung cancer screening has been investigated and applied as a medical practice. InferRead Lung CT.AI by Infervision is a dedicated post processing application that generates CADe marks as an overlay on the original CT series intended to aid the radiologist in the detection of pulmonary nodules. This study was designed to evaluate radiologists' performance in detecting actionable nodules on chest CT when aided by InferRead.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Lung cancer screening eligible patients

Exclusion Criteria:

-

Study is for people with:

Lung Cancer

Estimated Enrollment:

250

Study ID:

NCT04119960

Recruitment Status:

Completed

Sponsor:

Infervision

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Maryland Medical Center
Baltimore Maryland, 21201, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

250

Study ID:

NCT04119960

Recruitment Status:

Completed

Sponsor:


Infervision

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider